New 2013 incidence peak in childhood narcolepsy: more than vaccination?

Zhang, Zhongxing; Gool, Jari; Fronczek, Rolf; Dauvilliers, Yves; Bassetti, Claudio L A; Mayer, Geert; Plazzi, Giuseppe; Pizza, Fabio; Santamaria, Joan; Partinen, Markku; Overeem, Sebastiaan; Peraita-Adrados, Rosa; da Silva, Antonio Martins; Sonka, Karel; Del Rio-Villegas, Rafael; Heinzer, Raphael; Wierzbicka, Aleksandra; Young, Peter; Högl, Birgit; Manconi, Mauro; ... (2021). New 2013 incidence peak in childhood narcolepsy: more than vaccination? Sleep, 44(2) Oxford University Press 10.1093/sleep/zsaa172

[img] Text
Zhang__2020__New_2013_incidence_peak_in_childhood_narcolepsy.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

Increased incidence rates of narcolepsy type-1 (NT1) have been reported world-wide after the 2009-2010 H1N1 influenza pandemic (pH1N1). While some European countries found an association between the NT1 incidence increase and the H1N1 vaccination Pandemrix, reports from Asian countries suggested the H1N1 virus itself to be linked to the increased NT1 incidence. Using robust data-driven modelling approaches, i.e., locally estimated scatterplot smoothing methods, we analyzed the number of de-novo NT1 cases (n= 508) in the last two decades using the European Narcolepsy Network database. We confirmed the peak of NT1 incidence in 2010, i.e., 2.54-fold (95% confidence interval [CI]: [2.11, 3.19]) increase in NT1 onset following 2009-2010 pH1N1. This peak in 2010 was found in both childhood NT1 (2.75-fold increase, 95% CI: [1.95, 4.69]) and adulthood NT1 (2.43-fold increase, 95% CI: [2.05, 2.97]). In addition, we identified a new peak in 2013 that is age-specific for children/adolescents (i.e., 2.09-fold increase, 95% CI: [1.52, 3.32]). Most of these children/adolescents were HLA DQB1*06:02 positive and showed a subacute disease onset consistent with an immune-mediated type of narcolepsy. The new 2013 incidence peak is likely not related to Pandemrix as it was not used after 2010. Our results suggest that the increased NT1 incidence after 2009-2010 pH1N1 is not unique and our study provides an opportunity to develop new hypotheses, e.g., considering other (influenza) viruses or epidemiological events to further investigate the pathophysiology of immune-mediated narcolepsy.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Bassetti, Claudio; Mathis, Johannes and Khatami, Ramin

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1550-9109

Publisher:

Oxford University Press

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

30 Dec 2020 12:09

Last Modified:

14 Feb 2021 01:35

Publisher DOI:

10.1093/sleep/zsaa172

PubMed ID:

32909046

Uncontrolled Keywords:

Childhood narcolepsy H1N1 influenza Narcolepsy

BORIS DOI:

10.48350/149353

URI:

https://boris.unibe.ch/id/eprint/149353

Actions (login required)

Edit item Edit item
Provide Feedback